Skip to main content

Vaxxinity, Inc.

VAXXDelisted Apr 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001851657

Vaxxinity, Inc. was delisted on Apr 29, 2024; its insiders filed their last Form 4 on Apr 29, 2024; 58 institutions reported holding it in 13F filings for Q1 2024, worth $8.73M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Vaxxinity, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of VAXX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders29290
Shares26.1M26.3M+143.4K (+0.5%)
Value$38.2M$48.5M+$10.3M (+27.0%)

New holders (8)

Institutions that held Vaxxinity, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to VAXX in Q3 2022
InstitutionSharesValue% of portfolio
BlackRock Inc.373,261$739.0K0.00%
First Republic Investment Management, Inc.199,022$394.0K0.00%
Bridgeway Capital Management, LLC74,400$147.0K0.00%
Northern Trust Corp62,833$124.0K0.00%
Charles Schwab Investment Management Inc22,917$46.0K0.00%
UBS Group AG5,856$12.0K0.00%
BNP Paribas Arbitrage, SA92$1820.00%
Wells Fargo & Company238$00.00%

Sold out (8)

Institutions that held Vaxxinity, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of VAXX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Element Capital Management LLC376,886$592.0K
Squarepoint Ops LLC15,417$24.0K
Dynamic Technology Lab Private Ltd13,582$21.0K
Virtu Financial LLC12,760$20.0K
FNY Investment Advisers, LLC11,000$17.0K
Citigroup Inc1,447$2.00K
Royal Bank of Canada1,000$2.00K
Tower Research Capital LLC (TRC)1,193$1.00K